[心脏起搏期间持续口服抗凝治疗：BRUISE CONTROL研究] - Suppr | 超能文献

[Continued oral anticoagulation during cardiac pacing: the BRUISE CONTROL study].

作者信息

Proietti Riccardo, Birnie David H, Healey Jeff S, Verma Atul, Essebag Vidal

出版信息

G Ital Cardiol (Rome). 2013 Nov;14(11):724-5. doi: 10.1714/1360.15084.

DOI:10.1714/1360.15084

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Continued oral anticoagulation during cardiac pacing: the BRUISE CONTROL study].[心脏起搏期间持续口服抗凝治疗：BRUISE CONTROL研究]

G Ital Cardiol (Rome). 2013 Nov;14(11):724-5. doi: 10.1714/1360.15084.

2

[The BRUISE CONTROL study].[瘀伤控制研究]

G Ital Cardiol (Rome). 2013 Nov;14(11):719-23. doi: 10.1714/1360.15083.

3

A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation.一项比较在起搏器或除颤器植入后6小时或24小时开始使用肝素的随机试验。

J Am Coll Cardiol. 2000 Jun;35(7):1915-8. doi: 10.1016/s0735-1097(00)00633-1.

4

Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2.直接口服抗凝剂、华法林和抗血小板药物对装置袋血肿风险的影响：BRUISE CONTROL 1 和 2 的联合分析。

Circ Arrhythm Electrophysiol. 2019 Oct;12(10):e007545. doi: 10.1161/CIRCEP.119.007545. Epub 2019 Oct 15.

5

Use of oxidized regenerated cellulose to prevent pocket hematomas after cardiac electronic device implantation in patients on anticoagulants or dual antiplatelet therapy.在接受抗凝治疗或双联抗血小板治疗的患者中，使用氧化再生纤维素预防心脏电子设备植入术后的囊袋血肿。

Int J Cardiol. 2013 Oct 9;168(4):4406-7. doi: 10.1016/j.ijcard.2013.05.037. Epub 2013 May 22.

6

Pacemaker or defibrillator surgery without interruption of anticoagulation.起搏器或除颤器手术不停抗凝治疗。

N Engl J Med. 2013 May 30;368(22):2084-93. doi: 10.1056/NEJMoa1302946. Epub 2013 May 9.

7

Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.动脉血栓栓塞事件中、高风险患者器械手术时持续使用与中断使用新型口服抗凝药的策略：BRUISE CONTROL-2试验

Am Heart J. 2016 Mar;173:102-7. doi: 10.1016/j.ahj.2015.12.007. Epub 2015 Dec 19.

8

Management of anticoagulation around pacemaker and defibrillator surgery.起搏器和除颤器手术围手术期的抗凝管理。

Circulation. 2014 May 20;129(20):2062-5. doi: 10.1161/CIRCULATIONAHA.113.006027.

9

Cost effectiveness of continued-warfarin versus heparin-bridging therapy during pacemaker and defibrillator surgery.起搏器和除颤器手术期间持续使用华法林与肝素桥接治疗的成本效益

J Am Coll Cardiol. 2015 Mar 10;65(9):957-9. doi: 10.1016/j.jacc.2014.11.060.

10

Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies.接受电生理设备植入的华法林长期抗凝患者发生囊袋血肿的风险：不同围手术期管理策略的比较

Eur Rev Med Pharmacol Sci. 2015 Apr;19(8):1461-79.

引用本文的文献

1

Pulsed electron avalanche knife (PEAK) PlasmaBlade™ in pacemaker and defibrillator procedures.脉冲电子雪崩刀（PEAK）PlasmaBlade™在起搏器和除颤器手术中的应用

Eur J Med Res. 2017 Nov 21;22(1):49. doi: 10.1186/s40001-017-0292-7.